In vivo functional imaging with SPECT and PET

Radiochimica Acta

Volumn 89, Issue 4-5, 2001, Pages 203-214

  Herzog, H ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Functional imaging; Gamma camera; Positron emission tomography; Radiopharmaceuticals; Single photon emission computed tomography

Indexed keywords

RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT;

CONFERENCE PAPER; HISTORY OF MEDICINE; IN VIVO STUDY; INTERMETHOD COMPARISON; METHODOLOGY; NUCLEAR MEDICINE; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTIGRAPHY; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0034967137     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2001.89.4-5.203     Document Type: Conference Paper

References (87)

1. Image separation radioisotope scanning
2. Positron scanner for locating brain tumors
3. Representation of a function by its line integrals, with some radiological applications. II
4. Computerized transverse axial scanning (tomography) Part I: Description of system
5. Multiple plane tomographic scanner
6. Continuous-slice PENN-PET: A positron tomograph with volume imaging capability
7. 3D PET using a conventional multislice tomograph without septa
8. Emission computed tomography
9. Über die Bestimmung von Funktionen durch ihre Integralwerte längs gewisser Mannigfaltigkeiten
10. Three-dimensional reconstruction from radiographs and electron micrographs: Application of convolutions instead of Fourier transforms
11. Maximum likelihood reconstruction for emission tomography
12. Iterative reconstruction of PET images using a high-overrelaxation single-projection algorithm
13. Accelerated image reconstruction using ordered subsets of projection data
14. Statistical models for PET and SPECT data
15. Quantification in positron emission computed tomography: I. Effect of object size
16. Three-dimensional image reconstruction from complete projections
17. Analytic three-dimensional image reconstruction using all detected events
18. Treatment of axial data in three-dimensional PET
19. Exact and approximate rebinning algorithms for 3-D PET data
20. Corrections for attenuation, scattered radiation, and random coincidences in a ring detector positron emission transaxial tomograph
21. Attenuation correction in PET using single photon transmission measurement
22. 137Cs source
23. Gamma camera emission tomography
24. A method for attenuation correction in radionuclide computed tomography
25. Improved SPECT quantification using compensation for scattered photons
26. Generalized scatter correction method in SPECT using point scatter distribution functions
27. Scatter correction in SPECT using non-uniform attenuation data
28. Attenuation and scatter correction in SPECT for sources in a nonhomogeneous object: A Monte Carlo study
29. A single scatter simulation technique for scatter correction in 3D PET
30. Scatter correction method for 3D PET using 2D fitted Gaussian functions
31. Correction for scattered radiation in a ring detector positron camera by integral transformation of the projections
32. Quantification in positron emission computed tomography: 4. Effect of accidental coincidences
33. 99mTc
34. 99mTc-labelled radiopharmaceutical for cerebral blood flow imaging
35. Characterization of Technetium-99m-L-ECD for brain perfusion imaging, Part I: Pharmacology of Technetium-99m-ECD in non human primates
36. 123I-iodophenylalcylamines in rat brain
37. Imaging and epilepsy
38. Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical focus
39. 123I]beta-CIT and SPECT: An exploratory study
40. I-123-IBZM: A new CNS D2 receptor agent: Biodistribution and dosimetry in humans
41. Iodine-123- 1BF SPECT evaluation of extrapyramidal diseases
42. Imaging benzodiazepine receptors in the human brain by Single Photon Emission Computed Tomography SPECT
43. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands
44. 124IMT
45. 11C]-L-methionine uptake in cerebral gliomas: A comparative study using SPECT and PET
46. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: Human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging
47. Biokinetics of technetium-99m-tetrofosmin: Myocardial perfusion imaging agent: Implications for a one-day imaging protocol
48. Thallium-201 for medical use, I
49. 123I-iodoheptadecanoic acid in patients with idiopathic congestive cardiomyopathy
50. BMIPP-design and development
51. 15-p-I-123-iodophenyl-pentadecanoic acid as a tracer of lipid metabolism: Comparison with C-14-palmitate in murine tissues
52. Fatty acids for myocardial imaging
53. Meta-iodobenzyl-guanidine to map scintigraphically the adrenergic nervous system in man
54. Somatostatin-receptor imaging in the localization of endocrine tumours
55. 131I]-MIBG scintigraphy performed one week after administration in diagnosing pheochromocytoma
56. The role of 67Ga-scintigraphy in evaluating the results of therapy of lymphoma patients
57. Nuclear medicine procedures in lung cancer
58. Tumor imaging with monoclonal antibodies
59. Hepatic SPECT imaging in the detection and clinical assessment of hepatocellular disease
60. Hepatobiliary scintigraphy in current pediatric practice
61. Early dynamic SPECT acquisition for the imaging of hepatic hemangiomas utilizing Tc-99m labeled red blood cells
62. Abdominal SPECT imaging
63. Renal single photon emission computed tomography: Should we do it?
64. Radionuclide imaging of nonosseous infection
65. Orthopedic pathology of the lower extremities: Scintigraphic evaluation in the thigh, knee, and leg
66. 14C]deoxyglucose method for the measurement of focal cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat
67. The applications of PET in clinical oncology
68. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method
69. 18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man
70. Positron emission tomography studies of the brain
71. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system
72. Neurofunctional correlates of encoding and retrieval in declarative associative learning
73. 11C-labelled amino acids
74. Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development
75. The advantage of using positron emission tomography in drug research
76. Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness
77. New framework for investigating antipsychotic action in humans: Lessons from PET imaging
78. Recent advances in psychiatric brain imaging
79. Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography
80. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET
81. 18F]altanserin: Results in young normal controls
82. Noninvasive quantification of regional myocardial blood flow with N-13 ammonia and dynamic PET
83. 2(15)O
84. Economic analysis of clinical positron emission tomography of the heart with rubidium-82
85. Basic ideas and principles for quantifying regional blood flow with nuclear medical techniques
86. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects
87. Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction